Podcast by ISTH
Importance of Monitoring Individuals With Hemophilia for Safety and Efficacy - Short Term/Long Term by ISTH
Gene Therapy in Hemophilia Ongoing and Future Research and What to Expect by ISTH
Patient Perspectives for Hemophilia in Gene Therapy by ISTH
Gene Therapy as a Global Solution by ISTH
Preparing Treatment Centers for Administration by ISTH
Gene Therapy for Hemophilia A and B Compared to Available Treatments by ISTH
Listen as Dr. Margareth Ozelo from the University of Campinas in Brazil discusses the latest clinical trial updates in Gene Therapy for Hemophilia B. This podcast is part of a comprehensive educational resource designed by leading experts for the global hemophilia community to help you stay abreast of the evolving science and latest clinical advancements in gene therapy in hemophilia. Visit www.genetherapy.isth.org for more information.
Listen as Dr. Margareth Ozelo from the University of Campinas in Brazil discusses the latest clinical trial updates in Gene Therapy for Hemophilia A. This podcast is part of a comprehensive educational resource designed by leading experts for the global hemophilia community to help you stay abreast of the evolving science and latest clinical advancements in gene therapy in hemophilia. Visit www.genetherapy.isth.org for more information.
Advances in MS Assessment: Biomarkers and Imaging by ISTH
History of EAHAD and the Upcoming Congress by ISTH
ISTH Gene Therapy for Hemophilia Initiative and EAHAD’s Role by ISTH
Andrew D. Leavitt, MD discusses the reliability and accessibility of gene therapy for hemophilia.
Latest Advances in Gene Therapy for Hemophilia by ISTH
This activity is intended for physicians (hematologists), nurse practitioners, physician assistants, and nurses managing patients with hemophilia. The activity is also intended for scientists with an interest in basic, translational, and clinical research in hemophilia around the world.
This activity is intended for physicians (hematologists), nurse practitioners, physician assistants, and nurses managing patients with hemophilia. The activity is also intended for scientists with an interest in basic, translational, and clinical research in hemophilia around the world.
This activity is intended for physicians (hematologists), nurse practitioners, physician assistants, and nurses managing patients with hemophilia. The activity is also intended for scientists with an interest in basic, translational, and clinical research in hemophilia around the world.
This activity is intended for physicians (hematologists), nurse practitioners, physician assistants, and nurses managing patients with hemophilia. The activity is also intended for scientists with an interest in basic, translational, and clinical research in hemophilia around the world.
This activity is intended for physicians (hematologists), nurse practitioners, physician assistants, and nurses managing patients with hemophilia. The activity is also intended for scientists with an interest in basic, translational, and clinical research in hemophilia around the world.
What Do Hemophilia Treatment Centers Need to Consider for the Availability of Gene Therapy? by ISTH
Laboratory Measurement of Hemophilia Gene Therapy Products/Factor Activity by ISTH
Hemophilia Gene Therapy and Patients with History of Inhibitors by ISTH
Interpreting Vector Doses in Hemophilia Gene Therapy Clinical Trials by ISTH
Long-Term Monitoring Following Hemophilia Gene Therapy by ISTH
Factor IX Gene Therapy Clinical Trials Update by ISTH
Gene Editing and Cell-Based Therapy for Hemophilia by ISTH
Next Generation Gene Therapies for Hemophilia by ISTH
Factor VIII Gene Therapy Clinical Trials Update by ISTH
Challenges Associated with AAV as a Tool for Delivering Therapeutic Transgenes by ISTH